Assessment of minimal residual disease in myeloma and the need for a consensus approach.
about
Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life studyUtilizing next-generation sequencing in the management of multiple myeloma.Diagnosis of chronic lymphoproliferative disorders by flow cytometry using four-color combinations for immunophenotyping: A proposal of the Brazilian Group of Flow Cytometry (GBCFLUX).Introduction to multiple myeloma special issue: The flow cytometric detection of minimal residual disease.Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.Myeloma minimal residual disease testing in the United States: Evidence of improved standardization.Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders.Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.Minimal residual disease analysis in myeloma - when, why and where.Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms.
P2860
Q36705534-D2461179-2B44-4521-BCEF-827BB86C9FC2Q38681814-D118C623-41BB-46AF-BBC6-4E0EBCF2A754Q38881884-B75AAB55-10CA-4BFB-A8B0-3F5DEC8736F5Q40968571-9E694795-3C9A-458E-A3B3-43D28E039F8BQ42050819-6C450C69-284B-4006-B82E-A7A6A44F31EEQ46809405-27B073D3-9C62-44FE-AFA7-2CBA2E879CD0Q47438586-5F7BC2FD-E4B4-4C94-937D-6FD4563CB690Q49641900-3E5EFC3B-C8A9-4067-AD40-6210A68DC420Q50092746-A1DD08AE-718E-46F1-9F25-793FBC0CF9B2Q50197867-01E669ED-AD04-4791-98A2-9ADA0A5CC6E8
P2860
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
@en
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
@en-gb
type
label
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
@en
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
@en-gb
prefLabel
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
@en
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
@en-gb
P2860
P356
P1476
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
@en
P2093
Bruno Paiva
Maryalice Stetler-Stevenson
P2860
P356
10.1002/CYTO.B.21272
P577
2015-07-22T00:00:00Z